Therapy Areas: Vaccines
Labcorp Receives Emergency Use Authorization for First Non-Prescription At-Home Collection Kit for Combined COVID-19, Flu and RSV Detection
19 May 2022 - - US-based life sciences company Labcorp (NYSE: LH) has received Emergency Use Authorization from the US Food and Drug Administration for a combined at-home collection kit available...
Regencell Bioscience Posts Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19 in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period
19 May 2022 - - Hong Kong-based bioscience company Regencell Bioscience Holdings Ltd. (NASDAQ: RGC) has posted results from an analysis of a total of 51 individuals enrolled in its additional Eva...
epocrates Launches Long COVID-19 Tool and Incorporates Late-Breaking Updates to an Expanding Library of Clinical Decision Support Guidelines
19 May 2022 - - US-based digital clinical decision support provider epocrates, an athenahealth, Inc. company, has recently made to its decision support tool content, all of which provides clinicians w...
PDS Biotechnology names senior vice president Business Development
19 May 2022 - PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of molecularly targeted cancer immunotherapies and infectious disease v...
Osivax Enters Research Collaboration with the NIAID for the Evaluation of Combination Approach to Broad-Spectrum Influenza Vaccines
18 May 2022 - - French biopharmaceutical company Osivax, which is developing vaccines to provide broad-spectrum protection against highly mutating infectious viruses and diseases, has entered a resear...
Pfizer and BioNTech granted US EUA for booster dose of their COVID-19 vaccine in children 5 to 11
18 May 2022 - Us-based pharmaceutical company Pfizer Inc. (NYSE: PFE) and Germany-based BioNTech SE (Nasdaq: BNTX) announced on Tuesday the US Food and Drug Administration (FDA) expanded emergency use...